• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Anebulo Pharmaceuticals, Inc. - Common Stock (NQ:ANEB)

1.140 -0.050 (-4.20%)
Streaming Delayed Price Updated: 4:00 PM EST, Jan 9, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 41,509
Open 1.210
Bid (Size) 1.100 (900)
Ask (Size) 1.140 (2,000)
Prev. Close 1.190
Today's Range 1.110 - 1.210
52wk Range 0.9001 - 3.420
Shares Outstanding 41,084,731
Dividend Yield N/A
Chart for  (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
Anebulo Pharmaceuticals Announces Its Intent to Commence a Self Tender Offer
December 22, 2025
From Anebulo Pharmaceuticals, Inc.
Via Business Wire
News headline image
Anebulo Pharmaceuticals Reports First Quarter Fiscal Year 2026 Financial Results and Recent Updates
November 13, 2025
From Anebulo Pharmaceuticals, Inc.
Via Business Wire

Performance

YTD
+0.9%
+0.9%
1 Month
-49.1%
-49.1%
3 Month
-50.9%
-50.9%
6 Month
-29.2%
-29.2%
1 Year
-21.9%
-21.9%

More News

Read More
News headline image
Anebulo Pharmaceuticals Reports Fourth Quarter and Fiscal Year 2025 Financial Results and Recent Updates
September 29, 2025
From Anebulo Pharmaceuticals, Inc.
Via Business Wire
News headline image
Anebulo Pharmaceuticals Announces First Patients Dosed in Phase 1 Single Ascending Dose Study of Intravenous Selonabant, under Development for Acute Cannabis-Induced Toxicity
September 25, 2025
From Anebulo Pharmaceuticals, Inc.
Via Business Wire
News headline image
Deal Dispatch: Need M&A Approval? FCC Chair Explains How To Get It ↗
September 19, 2025
Via Benzinga
News headline image
Which stocks are gapping on Friday? ↗
September 12, 2025
Via Chartmill
News headline image
Top movers in Friday's pre-market session ↗
September 12, 2025
Via Chartmill
News headline image
12 Health Care Stocks Moving In Friday's Pre-Market Session ↗
September 12, 2025
Via Benzinga
News headline image
Anebulo Pharmaceuticals Announces Update on Going Private Transaction and Strategic Alternatives
September 12, 2025
From Anebulo Pharmaceuticals, Inc.
Via Business Wire
News headline image
On Thursday, there are stocks with unusual volume. Let's take a look. ↗
July 24, 2025
Via Chartmill
News headline image
Crude Oil Falls; Thermo Fisher Scientific Earnings Top Views ↗
July 23, 2025
Via Benzinga
News headline image
12 Health Care Stocks Moving In Wednesday's Intraday Session ↗
July 23, 2025
Via Benzinga
News headline image
Dow Surges Over 200 Points; AT&T Posts Upbeat Earnings ↗
July 23, 2025
Via Benzinga
Topics Stocks
News headline image
12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗
July 23, 2025
Via Benzinga
News headline image
Anebulo Pharmaceuticals Approves Plan to Terminate Registration of Its Common Stock
July 23, 2025
From Anebulo Pharmaceuticals, Inc.
Via Business Wire
News headline image
Anebulo Pharmaceuticals Reports Third Quarter Fiscal Year 2025 Financial Results and Recent Updates
May 13, 2025
From Anebulo Pharmaceuticals, Inc.
Via Business Wire
News headline image
12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗
March 27, 2025
Via Benzinga
News headline image
12 Health Care Stocks Moving In Thursday's Intraday Session ↗
March 13, 2025
Via Benzinga
News headline image
Anebulo Pharmaceuticals Reports Second Quarter Fiscal Year 2025 Financial Results and Recent Updates
February 14, 2025
From Anebulo Pharmaceuticals, Inc.
Via Business Wire
News headline image
12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗
December 26, 2024
Via Benzinga
News headline image
12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗
December 24, 2024
Via Benzinga
News headline image
Anebulo Pharmaceuticals Announces Positive Regulatory Update for Selonabant in Acute Cannabis-Induced Toxicity in Children and Capital Raise
December 23, 2024
From Anebulo Pharmaceuticals, Inc.
Via Business Wire
News headline image
Anebulo Pharmaceuticals Reports First Quarter Fiscal Year 2025 Financial Results and Recent Updates
November 13, 2024
From Anebulo Pharmaceuticals, Inc.
Via Business Wire
News headline image
Anebulo Pharmaceuticals Reports Fourth Quarter and Fiscal Year 2024 Financial Results and Recent Updates
September 25, 2024
From Anebulo Pharmaceuticals, Inc.
Via Business Wire
News headline image
Anebulo Pharmaceuticals Awarded NIDA Grant for its Investigational IV Treatment for Acute Cannabis-Induced Toxic Effects
July 22, 2024
From Anebulo Pharmaceuticals, Inc.
Via Business Wire

Frequently Asked Questions

Is Anebulo Pharmaceuticals, Inc. - Common Stock publicly traded?
Yes, Anebulo Pharmaceuticals, Inc. - Common Stock is publicly traded.
What exchange does Anebulo Pharmaceuticals, Inc. - Common Stock trade on?
Anebulo Pharmaceuticals, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Anebulo Pharmaceuticals, Inc. - Common Stock?
The ticker symbol for Anebulo Pharmaceuticals, Inc. - Common Stock is ANEB on the Nasdaq Stock Market
What is the current price of Anebulo Pharmaceuticals, Inc. - Common Stock?
The current price of Anebulo Pharmaceuticals, Inc. - Common Stock is 1.140
When was Anebulo Pharmaceuticals, Inc. - Common Stock last traded?
The last trade of Anebulo Pharmaceuticals, Inc. - Common Stock was at 01/09/26 04:00 PM ET
What is the market capitalization of Anebulo Pharmaceuticals, Inc. - Common Stock?
The market capitalization of Anebulo Pharmaceuticals, Inc. - Common Stock is 46.84M
How many shares of Anebulo Pharmaceuticals, Inc. - Common Stock are outstanding?
Anebulo Pharmaceuticals, Inc. - Common Stock has 47M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap